Forbes March 27, 2024
Alex Knapp

Biotech startup eGenesis developed a gene-edited kidney that was successfully transplanted into a living patient last week. Its CEO says the company is just getting started.

Last Thursday, surgeons at Massachusetts General Hospital announced that for the first time, a living human patient had received a kidney transplant from a pig. This scientific breakthrough represents hope for the dozens of people who die every day waiting on an organ transplant, the hospital’s transplant director Joren Masden said at a press conference following the announcement. “The dream of transplant researchers – the Holy Grail – has been to use pig organs to supplement human organs to solve the problem of organ shortage,” he said.

Of course, it wasn’t as simple as...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health System / Hospital, Patient / Consumer, Pharma / Biotech, Provider
FDA Update for Week of April 22, 2024: Second Gene Therapy for Hemophilia B
Why Conflicts Of Interest May Not Be As Bad As You Think (And Besides We All Have Them!)
11 drugs now in shortage
AbbVie tries to reassure investors on Humira biosimilar threat
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder

Share This Article